| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/16/2000 | EP0979655A1 Means for treatment of infections caused by RNA-Virusses such as HIV |
| 02/16/2000 | EP0979654A1 Activated vitamin d 3? emulsion-type lotions |
| 02/16/2000 | EP0979649A2 Use of copolymers comprising N-vinylpyrrolidone and vinylacetate for the production of solid oral pharmaceutic and cosmetic compositions |
| 02/16/2000 | EP0979648A2 Microspheres of esters of hyaluronic acid for controlled release of an active |
| 02/16/2000 | EP0979647A1 Fat emulsion for oral administration |
| 02/16/2000 | EP0979311A1 $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES |
| 02/16/2000 | EP0979243A2 Activation of peptides |
| 02/16/2000 | EP0979238A1 Method of alleviating neuropathic pain |
| 02/16/2000 | EP0979225A1 Compounds and compositions for delivering active agents |
| 02/16/2000 | EP0979224A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 02/16/2000 | EP0979105A1 Topical nasal antiinflammatory compositions |
| 02/16/2000 | EP0979095A2 Use of conantokins for producing analgesia or for neuroprotection |
| 02/16/2000 | EP0979091A1 Pourable alginate compositions |
| 02/16/2000 | EP0979087A1 Analgesic combination |
| 02/16/2000 | EP0979072A1 Transdermal device for the delivery of testosterone |
| 02/16/2000 | EP0979071A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 02/16/2000 | EP0979070A1 Adherent microcapsules containing biologically active ingredients |
| 02/16/2000 | EP0979069A1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 02/16/2000 | EP0694310B1 Reversible, thermally gelling water-base medicinal composition |
| 02/16/2000 | EP0665009B1 Crystalline condition dislocating method |
| 02/16/2000 | EP0642335B1 Controlled release preparation containing a salt of morphine |
| 02/16/2000 | CN2363709Y Automatic capsule cutter |
| 02/16/2000 | CN2363708Y Tablet with female pattern |
| 02/16/2000 | CN1244893A Disinfecting microemulsions |
| 02/16/2000 | CN1244869A Crystal form O of clarithromycin |
| 02/16/2000 | CN1244806A Compositions for transdermal administration of streoid drugs |
| 02/16/2000 | CN1244805A Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 02/16/2000 | CN1244797A Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 02/16/2000 | CN1244796A Pellets having a core coated with an antifungal and a polymer |
| 02/16/2000 | CN1244795A Method of manufacturing porous matrix-type controlled release systems using emulsion technique |
| 02/16/2000 | CN1244794A Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same |
| 02/16/2000 | CN1244790A Aerosol device based on alcoholic compositions of binding materials containing anionic grafted silicon polymers |
| 02/16/2000 | CN1244535A Preparation of Fenbijie general glycoside as a new anticarcinogen |
| 02/16/2000 | CN1244429A Hedgelog protein medicinal composition and its use |
| 02/16/2000 | CN1244426A Fast-acting nemostatic pellet |
| 02/16/2000 | CN1244423A Vanilla powder and its preparation |
| 02/16/2000 | CN1244422A Pain relieving ointment and its preparation |
| 02/16/2000 | CN1244419A Naojinzhi oral liquor and its preparation |
| 02/16/2000 | CN1244403A Preparation of isotomic Shengmei injecta |
| 02/16/2000 | CN1244402A Supporting for treating prostate disease |
| 02/16/2000 | CN1244398A Improved tincture with both Chinese and Western medicines for dermatomycosis |
| 02/16/2000 | CN1244393A Gastritis treating tablet |
| 02/16/2000 | CN1244392A Externally used medicine for treating tinea |
| 02/16/2000 | CN1244391A Long-acting analgesic used mainly for operational cut and traumatic wound |
| 02/16/2000 | CN1244390A Medical metronidazole toothpaste |
| 02/16/2000 | CN1049423C 芳香羧酸衍生物 Aromatic carboxylic acid derivatives |
| 02/16/2000 | CN1049356C Protein-containing aqueous solutions |
| 02/16/2000 | CN1049351C Chinese patented drug for curing cerebrovascular disease |
| 02/16/2000 | CN1049346C Health-care medicinal bag capable of preventing disease |
| 02/16/2000 | CN1049345C Externally-used plaster for treating rheumatism |
| 02/16/2000 | CN1049337C Concentrated aqueous solution of rotary enzyme inhibitor |
| 02/16/2000 | CN1049333C Process for producing fine particulate materials |
| 02/15/2000 | US6025507 Borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025396 Stable prostaglandin E1-containing injectable composition |
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025389 A mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition. |
| 02/15/2000 | US6025357 Anthelmintic paste |
| 02/15/2000 | US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and |
| 02/15/2000 | US6025337 Solid microparticles for gene delivery |
| 02/15/2000 | US6025334 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| 02/15/2000 | US6025198 Antisense modulation of Ship-2 expression |
| 02/15/2000 | US6024987 Pharmaceutical, orally applicable composition |
| 02/15/2000 | US6024983 Potentiating immunology biocompatible excipients in microcapsules |
| 02/15/2000 | US6024982 Immediate release tablet cores of insoluble drugs having sustained-release coating |
| 02/15/2000 | US6024981 Rapidly dissolving robust dosage form |
| 02/15/2000 | US6024980 Multiphase soft gelatin dosage form |
| 02/15/2000 | US6024979 Treatment of infections in ruminants with bolus |
| 02/15/2000 | US6024978 Oral drug composition with lipophilic compounds |
| 02/15/2000 | US6024976 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 02/15/2000 | US6024975 Method of transdermally administering high molecular weight drugs with a polymer skin enhancer |
| 02/15/2000 | US6024974 Transdermal drug delivery |
| 02/15/2000 | US6024968 Matrices with dispersants of esters, ethers or pyrrolidones and colors |
| 02/15/2000 | US6024959 Pharmaceutical composition containing pectin and a phospholipid used as an antidiarrheal and antiulcer agent |
| 02/15/2000 | US6024940 Antiinflammatory agents for mammals |
| 02/15/2000 | US6024176 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 02/15/2000 | US6024090 Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| 02/15/2000 | CA2181391C Controlled release tabletted medicine |
| 02/15/2000 | CA2132001C Methods of treating cancer using modified c-reactive protein |
| 02/15/2000 | CA2047738C Dispensing device |
| 02/10/2000 | WO2000006659A1 Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition |
| 02/10/2000 | WO2000006609A1 Carrageenan compositions, and processes for their production |
| 02/10/2000 | WO2000006599A1 Inhibitors of hiv membrane fusion |
| 02/10/2000 | WO2000006579A2 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity |
| 02/10/2000 | WO2000006534A1 Compounds and compositions for delivering active agents |
| 02/10/2000 | WO2000006296A2 Microparticles produced from cyclic olefin copolymers and their use for the controlled release of active agents |
| 02/10/2000 | WO2000006243A2 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 02/10/2000 | WO2000006204A2 Genetically engineered cells and tissues |
| 02/10/2000 | WO2000006202A1 Virucide drug containing iodine |
| 02/10/2000 | WO2000006201A1 Process for the preparation of granular and porous sucralfate dry gel |
| 02/10/2000 | WO2000006194A2 Depletion of cells responsible for antibody-mediated graft rejection |
| 02/10/2000 | WO2000006184A1 Pulmonary delivery of active agents |
| 02/10/2000 | WO2000006179A1 Cryogranulation of activated protein c |
| 02/10/2000 | WO2000006161A1 Prevention of migraine recurrence |
| 02/10/2000 | WO2000006151A1 Sustained release nitric oxide producing agents |
| 02/10/2000 | WO2000006142A1 Injectable propofol formulations |
| 02/10/2000 | WO2000006138A2 Use of moclobemide for treating pain and other diseases |
| 02/10/2000 | WO2000006132A2 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease |
| 02/10/2000 | WO2000006131A1 Estradiol-containing patch for transdermal administration of hormones |
| 02/10/2000 | WO2000006130A1 Estradiol-containing patch for transdermal administration of hormones |